Profile
Michael Satow is a serial entrepreneur in Health and Wellness. Currently, he is Co-Founder and CEO of Bonafide Health, a leading women’s health company that has helped more than 850,000 women improve their health and quality of life since its founding in 2014. Bonafide is a digitally native dietary supplement brand that employs a nationwide field force of experienced medical sales representatives who target and educate more than 7,000 mainstream gynecologists, oncologists, and other healthcare providers. In November 2023, Pharmavite purchased Bonafide Health for $425 million.
Earlier, Michael served as CEO of Nutrition 21, a leading dietary ingredient company. In November 2021, Nutrition 21 was acquired by Everwell Health, a platform established by Roundtable Healthcare Partners at the time of the transaction. In November 2011, Michael and an investor group purchased Nutrition 21 in a bankruptcy sale, and over the next 10 years, Michael and his team built it into a leading dietary ingredient company serving more than 200 dietary supplements brands.
Earlier, Michael co-founded and served as a Board Member and COO of JDS
Pharmaceuticals, a psychiatric and women’s health focused specialty pharmaceutical company, which he successfully exited in 2007. Michael also co-founded and served as CEO of
MarketXT, a venture-backed financial technology company, which he successfully exited in 2000.
Michael is the Chairman of the Jed Foundation, the nation’s leading non-profit focused on the mental health and wellness of young people. He is a member of the Board of Visitors of Columbia University, and is a board member of several private companies.
Michael started his career as a lawyer, working as a commercial litigator in New York City and as a senior enforcement lawyer for the U.S. Securities and Exchange Commission. He holds a B.A. from Columbia College and a J.D. from Georgetown Law School.
Sessions